Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
logos LINCs Logo Mt Sinai Logo NIH Logo NCI Logo
Protein Page:
COL4A3 (human)
rdtyret
p Phosphorylation
ac Acetylation
me Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
ub Ubiquitylation
sm Sumoylation
ne Neddylation
gl O-GlcNAc
ga O-GalNAc
pa Palmitoylation
ad Adenylation
sn S-Nitrosylation
ca Caspase cleavage
sc Succinylation

Overview
COL4A3 Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen. Autoantibodies against the NC1 domain of alpha 3(IV) are found in Goodpasture syndrome, an autoimmune disease of lung and kidney. Defects in COL4A3 are a cause of Alport syndrome autosomal recessive (APSAR). APSAR is characterized by progressive glomerulonephritis, glomerular basement membrane defects, renal failure, sensorineural deafness and specific eye abnormalities (lenticonous and macular flecks). The disorder shows considerable heterogeneity in that families differ in the age of end-stage renal disease and the occurrence of deafness. Defects in COL4A3 are a cause of benign familial hematuria (BFH); also known as thin basement membrane nephropathy. BFH is characterized by persistent hematuria, an electron microscopically detectable thin glomerular basement membrane (GBM) and an autosomal dominant mode of inheritance. Renal function remains normal. In children, differentiation between BFH and AS can be difficult, because both disorders are manifested by persistent hematuria and thin GBM at that age. Defects in COL4A3 are a cause of Alport syndrome autosomal dominant (APSAD). Alport syndrome is characterized by progressive glomerulonephritis, glomerular basement membrane defects, renal failure, sensorineural deafness and specific eye abnormalities (lenticonous and macular flecks). The disorder shows considerable heterogeneity in that families differ in the age of end-stage renal disease and the occurrence of deafness. Belongs to the type IV collagen family. 5 isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Protein type: Secreted, signal peptide; Secreted
Chromosomal Location of Human Ortholog: 2q36-q37
Cellular Component: basement membrane; collagen type IV; endoplasmic reticulum; endoplasmic reticulum lumen; extracellular region; intracellular membrane-bound organelle
Molecular Function: extracellular matrix structural constituent; integrin binding; metalloendopeptidase inhibitor activity; protein binding; structural molecule activity
Biological Process: axon guidance; blood circulation; caspase activation; cell adhesion; cell proliferation; cell surface receptor linked signal transduction; collagen catabolic process; extracellular matrix disassembly; extracellular matrix organization and biogenesis; glomerular basement membrane development; negative regulation of angiogenesis; negative regulation of cell proliferation; sensory perception of sound
Disease: Alport Syndrome, Autosomal Dominant; Alport Syndrome, Autosomal Recessive; Hematuria, Benign Familial
Reference #:  Q01955 (UniProtKB)
Alt. Names/Synonyms: CO4A3; COL4A3; Collagen alpha-3(IV) chain; collagen IV, alpha-3 polypeptide; collagen, type IV, alpha 3 (Goodpasture antigen); Goodpasture antigen; Tumstatin
Gene Symbols: COL4A3
Molecular weight: 161,812 Da
Basal Isoelectric point: 9.28  Predict pI for various phosphorylation states
Select Structure to View Below

COL4A3

Protein Structure Not Found.


STRING  |  cBioPortal  |  Wikipedia  |  Reactome  |  neXtProt  |  Protein Atlas  |  BioGPS  |  Scansite  |  Pfam  |  Phospho.ELM  |  NetworKIN  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains  
Click here to view other types of protein modifications

Modification Sites in Parent Protein, Orthologs, and Isoforms  
 

Show Multiple Sequence Alignment


 LTP 

LTP: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 HTP 

HTP: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 1 T235‑p ERGVKGLtGPPGPPG
0 1 T243‑p GPPGPPGtVIVTLtG
0 1 T249‑p GtVIVTLtGPDNRTD
0 1 S382‑p GPPGVPGsPGSSRPG
0 1 T835‑p QQGRRGKtGPKGDPG
0 1 K924 SPGIPGVKGQRGTPG
0 1 K933 QRGTPGAKGEQGDKG
0 1 K1114 GSPGLPGKPGPHGDL
0 1 K1124 PHGDLGFKGIKGLLG
0 1 K1127 DLGFKGIKGLLGPPG
0 1 K1206‑m2 FPGLPGRkGAMGDAG
0 1 S1246‑p GNRGPPGsRGsPGAP
0 1 S1249‑p GPPGsRGsPGAPGPP
1 1 K1414‑ub EKGNKGSkGEPGPAG
2 0 S1435‑p LKGKRGDsGSPATWT
0 1 T1443‑p GSPATWTtRGFVFTR
1 0 S1452‑p GFVFTRHsQTTAIPS
0 1 S1576 PCPHGWISLWKGFSF
0 1 S1648‑p MFRKPIPstVKAGEL
0 1 T1649‑p FRKPIPstVKAGELE
  mouse

 
T235 ERGMKGLTGPPGPPG
T243 GPPGPPGTVIFTLTQ
T249 GTVIFTLTQPYNKSD
S382 GPPGVPGSPGLSRPG
T833 QPGRRGDTGPKGDPG
K922‑ac SLGIPGMkGEKGRPG
K931‑ac EKGRPGAkGERGEKG
K1112‑ac GSPGHPGkPGPAGDL
K1122‑ac PAGDLGLkGQkGFPG
K1125‑ac DLGLkGQkGFPGPPG
K1204 LSGLPGRKGVMGDVG
L1244 GDRGLPGLRGNPGEP
N1247 GLPGLRGNPGEPGPP
K1412 TKGNKGLKGQQGPPG
R1433 LKGNPGDRGTPATGT
M1442 TPATGTRMRGFIFTR
S1451 GFIFTRHSQTTAIPS
S1575‑p PCPQDWVsLWKGFSF
S1647 MFRKPIPSTVKAGDL
T1648 FRKPIPSTVKAGDLE
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.